Stavas J, Silva AL, Wooldridge TD, Aqeel A, et al. Rilparencel (Renal Autologous Cell Therapy-REACT(R)) for Chronic Kidney Disease and Type 1 and 2 Diabetes: Phase 2 Trial Design Evaluating Bilateral Kidney Dosing and Re-Dosing Triggers. Am J Nephrol 2024 Feb 29. doi: 10.1159/000537942.
PMID: 38423000